{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T00:11:39Z","timestamp":1699747899541},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":11498,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1981,2]]},"abstract":"<jats:p>1 The influence of spironolactone 25, 50, 100 and 200 mg daily, and placebo, on plasma potassium and other variables was examined in a random crossover study of 15 hypertensive patients taking bendrofluazide 10 mg daily. 2 Spironolactone produced significant dose\u2010 related increases in plasma potassium and aldosterone, and reductions in plasma sodium and bicarbonate. 3 In 14 compliant patients plasma concentrations of the major metabolite canrenone were related linearly to the dose of spironolactone, and there was less than twofold variation between patients. The plasma canrenone concentration correlated negatively with body weight (r = \u22120.77, P less than 0.001). 4 The plasma potassium response to spironolactone varied sevenfold between compliant patients. The response correlated negatively with placebo plasma potassium (r = \u22120.62, P less than 0.02), positively with plasma canrenone (r = +0.55, P less than 0.05), but was unrelated to plasma aldosterone (r = \u22120.22). In one patient relative resistance to spironolactone was attributed to exaggerated secondary hyperaldosteronism induced by the drug. 5 The variability in response to spironolactone between patients is such that fixed dose thiazide\u2010 spironolactone combination tablets are unlikely to prevent hypokalaemia reliably.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1981.tb01119.x","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T16:28:41Z","timestamp":1343320121000},"page":"153-158","source":"Crossref","is-referenced-by-count":5,"title":["Spironolactone in thiazide\u2010induced hypokalaemia: variable response between patients."],"prefix":"10.1111","volume":"11","author":[{"given":"LE","family":"Ramsay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Hettiarachchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"307S","article-title":"Competitive inhibition of 11\u03b2\u2010 and 18\u2010hydroxylases by spironolactone","volume":"51","author":"ABSHAGEN U.","year":"1976","journal-title":"Clin. Sci. mol. Med."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600661020"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1974.00320180125011"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00501467"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00501608"},{"key":"e_1_2_1_7_1","first-page":"411","article-title":"A comparison of double isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man","volume":"45","author":"FRASER R.","year":"1973","journal-title":"Clin. Sci. mol. Med."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)92869-9"},{"key":"e_1_2_1_9_1","first-page":"312","article-title":"A fluorimetric method for the determination of a major spironolactone (Aldactone) metabolite in human plasma","volume":"135","author":"GOCHMAN N.","year":"1962","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1974.tb00961.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-67-1-125"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1976192158"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.1974.03240050065033","article-title":"Management of potassium problems during long\u2010term diuretic therapy","volume":"230","author":"KOSMAN M.E.","year":"1974","journal-title":"J. Am. med. Ass."},{"key":"e_1_2_1_14_1","first-page":"519","article-title":"Diuretic therapy","volume":"219","author":"LANT A.","year":"1977","journal-title":"Practitioner"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/000456327801500114"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.38.10.1025"},{"key":"e_1_2_1_17_1","first-page":"113","article-title":"Antihypertensive effect of increasing doses of spironolactone","volume":"21","author":"OGILVIE R.I.","year":"1977","journal-title":"Clin. Pharmac. Ther."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977215602"},{"key":"e_1_2_1_19_1","first-page":"401","article-title":"Factors influencing serum potassium in treated hypertension","volume":"46","author":"RAMSAY L.E.","year":"1977","journal-title":"Q. J. Med."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.75"},{"key":"e_1_2_1_21_1","first-page":"529","article-title":"Rational potassium prescribing","volume":"219","author":"RAMSAY L.E.","year":"1977","journal-title":"Practitioner"},{"key":"e_1_2_1_22_1","first-page":"686","article-title":"Pharmacokinetics of spironolactone, canrenone and canrenoate\u2010K in humans","volume":"185","author":"SADEE W.","year":"1973","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00560381"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1981.tb01119.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1981.tb01119.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T15:59:02Z","timestamp":1699718342000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1981.tb01119.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1981,2]]}},"alternative-id":["10.1111\/j.1365-2125.1981.tb01119.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb01119.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,2]]}}}